Which sample types are suitable for detecting polyglycylation when utilizing your antibodies?

The antibodies we produce can identify polyglycylation across different sample types, such as cell lysates along with tissue extracts, and purified proteins. We adjust protocols to match your specific sample requirements. Contact us to discuss your project.

What are the differences between your antibodies and commercially available polyglycylation antibodies?

Through advanced production techniques and strict quality control measures our antibodies deliver exceptional specificity and sensitivity. Request a comprehensive analysis of our tailor-made solutions by contacting us.

Is it possible to create antibodies that target particular polyglycylation sites?

Our services include site-specific anti-polyglycylation antibodies, which researchers can use to explore the functions of individual polyglycylation sites. Reach out for a consultation.

What benefits do monoclonal antibodies have compared to polyclonal antibodies in detecting polyglycylation?

Monoclonal antibodies deliver precise targeting and uniform performance, but polyclonal antibodies yield stronger detection signals. We assist in selecting the most appropriate antibody type for your specific needs. Inquire for advice.

What kind of assistance do you receive following antibody generation?

Our support services include thorough antibody characterization data delivery as well as application-specific advice and troubleshooting assistance. Our goal is your success. Please inform us about the ways we can support you.

Polyglycylation Specific Antibody Discovery Service

Background Antibody Types Discovery Strategy Types of PTM Why Choose Us? FAQs

Do you encounter difficulties while researching protein polyglycylation or when you try to detect specific polyglycylated proteins and develop sensitive detection methods? Through our Polyglycylation-Specific Antibody Discovery Service, you receive precise antibodies that enhance your research using our cutting-edge antibody development platforms. Creative Biolabs' service delivers specialized antibody solutions for targeting polyglycylated proteins to achieve strong binding affinity and precise specificity.

Background

A target protein undergoes polyglycylation when a series of glycine residues is added through post-translational modification. The polyglycylation modification mainly targets tubulin which forms microtubules but can also modify other protein types. The regulation of microtubule dynamics and the function of cilia and flagella as well as protein-protein interactions depend crucially on polyglycylation. The modification participates in multiple cellular functions, such as cell division and intracellular transport as well as signal transduction. Multiple diseases, such as neurological disorders and cancer, have been linked to the improper regulation of polyglycylation processes. Research into polyglycylated proteins demands precise detection methods to reveal their biological functions and pathological roles. Our Polyglycylation Specific Antibody Discovery Service becomes essential because it equips researchers with the necessary tools for studying this vital modification.

Fig.1 Effects of polyglutamylation and polyglycination status on TTLL10 microtubule association.¹

Antibody Types

Our service provides both monoclonal and polyclonal antibodies that are produced from rabbit, mouse, and sheep host animals. The antibody types include:

Site-Specific Anti-Polyglycylation Antibodies: These antibodies target specific polyglycylation sites which facilitates the examination of targeted polyglycylation events.
Pan Anti-Polyglycylation Antibodies: The antibodies bind to polyglycylated proteins without discriminating modification sites which makes them ideal for measuring total polyglycylation levels.

Discovery Strategy

The development of our antibody services principally involves three distinct strategies.

Monospecific Anti-Polyglycylation Polyclonal Antibody Production: The process requires using a polyglycylation-specific antigen to immunize animals for producing highly specific polyclonal antibodies.

Fig. 2 General process of monospecific anti-polyglycination polyclonal antibody production. (Creative Biolabs Original)

Phage Display Strategy for Anti-Polyglycylation Monoclonal Antibody Discovery: The phage display method enables screening of antibody fragment libraries against polyglycylated antigens to produce high-affinity monoclonal antibodies.

Fig. 3 General process of phage display for anti-polyglycination monoclonal antibody discovery. (Creative Biolabs Original)

Hybridoma Strategy for Anti-Polyglycylation Monoclonal Antibody Discovery: The production of antibodies specific to polyglycylated proteins occurs through the fusion of B cells with myeloma cells to generate hybridomas.

Fig. 4 General process of hybridoma for anti-polyglycination monoclonal antibody discovery. (Creative Biolabs Original)

Types of PTM

We provide polyglycylation specific antibodies and antibodies targeting a variety of PTMs, as shown in the table below.

Why Choose Us?

Creative Biolabs stands out as a top antibody development service provider with proven expertise in producing high-grade antibodies for various targets including post-translational modifications. Our Polyglycylation Specific Antibody Discovery Service delivers multiple important benefits.

High Specificity: Our antigen design and screening methods are rigorous to generate antibodies that specifically target polyglycylated proteins and reduce unwanted interactions with unmodified proteins.
Customizable Solutions: Flexible service options allow us to meet your research needs by providing various host species, antibody types, and discovery strategies.
Fast Turnaround Time: Through our efficient production processes, we provide high-quality antibodies promptly to support accelerated research development.
Expert Team: Our team consists of experienced scientists who possess extensive knowledge in both antibody development and polyglycylation biology, which guarantees your project's success.
Proven Track Record: Our published data shows that we have an established record of successful antibody generation for multiple research applications.

FAQs

Which sample types are suitable for detecting polyglycylation when utilizing your antibodies?
The antibodies we produce can identify polyglycylation across different sample types, such as cell lysates along with tissue extracts, and purified proteins. We adjust protocols to match your specific sample requirements. Contact us to discuss your project.
What are the differences between your antibodies and commercially available polyglycylation antibodies?
Through advanced production techniques and strict quality control measures our antibodies deliver exceptional specificity and sensitivity. Request a comprehensive analysis of our tailor-made solutions by contacting us.
Is it possible to create antibodies that target particular polyglycylation sites?
Our services include site-specific anti-polyglycylation antibodies, which researchers can use to explore the functions of individual polyglycylation sites. Reach out for a consultation.
What benefits do monoclonal antibodies have compared to polyclonal antibodies in detecting polyglycylation?
Monoclonal antibodies deliver precise targeting and uniform performance, but polyclonal antibodies yield stronger detection signals. We assist in selecting the most appropriate antibody type for your specific needs. Inquire for advice.
What kind of assistance do you receive following antibody generation?
Our support services include thorough antibody characterization data delivery as well as application-specific advice and troubleshooting assistance. Our goal is your success. Please inform us about the ways we can support you.

Creative Biolabs delivers a complete polyglycylation specific antibody discovery service that develops custom solutions for producing specific high-quality antibodies. Our combined antibody development expertise and cutting-edge technologies allow us to create dependable research tools for polyglycylation studies. Please contact us if you need any information.

Reference

Cummings, Steven W., et al. "The TTLL10 polyglycylase is stimulated by tubulin glutamylation and inhibited by polyglycylation." bioRxiv (2024): 2024-03. Distributed under Open Access license CC 0, without modification.

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

	USA: Europe: Germany:
	Call us at: USA: UK: Germany:
	Fax:
	Email: